Related references
Note: Only part of the references are listed.Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?
Elisa Lucchini et al.
HAEMATOLOGICA (2019)
Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux
Samuel Deshayes et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
Ignacio Sanz et al.
FRONTIERS IN IMMUNOLOGY (2019)
BAFF and CD4+ T cells are major survival factors for long-lived splenic plasma cells in a B-cell-depletion context
Lan-Huong Thai et al.
BLOOD (2018)
The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus
Tineke Kraaij et al.
JOURNAL OF AUTOIMMUNITY (2018)
Vaccination establishes clonal relatives of germinal center T cells in the blood of humans
Antje Heit et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Pneumococcal vaccination in patients with systemic lupus erythematosus: A multicenter placebo-controlled randomized double-blind study
Sophie Grabar et al.
VACCINE (2017)
Pathogenesis of immune thrombocytopenia
Sylvain Audia et al.
AUTOIMMUNITY REVIEWS (2017)
Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort
Guillaume Moulis et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
The Effect of BAFF Inhibition on Autoreactive B-Cell Selection in Murine Systemic Lupus Erythematosus
Alexis Boneparth et al.
MOLECULAR MEDICINE (2016)
A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4)
Philip Young-Ill Choi et al.
BLOOD (2015)
Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab
Matthieu Mahevas et al.
JOURNAL OF AUTOIMMUNITY (2015)
Pathophysiology of T follicular helper cells in humans and mice
Hideki Ueno et al.
NATURE IMMUNOLOGY (2015)
BAFF Regulates Follicular Helper T Cells and Affects Their Accumulation and Interferon-γ Production in Autoimmunity
Christine M. Coquery et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis
Shaan Chugh et al.
LANCET HAEMATOLOGY (2015)
Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia
Sylvain Audia et al.
BLOOD (2014)
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients
Mehdi Khellaf et al.
BLOOD (2014)
Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration
James B. Bussel et al.
HAEMATOLOGICA (2014)
Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation
Radhika Goenka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Pathogenesis of immune thrombocytopenia
Douglas B. Cines et al.
PRESSE MEDICALE (2014)
Human Circulating PD-1+CXCR3-CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses
Michela Locci et al.
IMMUNITY (2013)
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
Matthieu Mahevas et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Long-lived plasma cells in autoimmunity: lessons from B-cell cepleting therapy
Matthieu Mahevas et al.
FRONTIERS IN IMMUNOLOGY (2013)
Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia
Francesco Zaja et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia
Donald M. Arnold et al.
BLOOD (2012)
BAFF and selection of autoreactive B cells
Zheng Liu et al.
TRENDS IN IMMUNOLOGY (2011)
Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab
Henrik E. Mei et al.
BLOOD (2010)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny
Jennifer H. Anolik et al.
CLINICAL IMMUNOLOGY (2007)
The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura
N Cooper et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Share Paper
